The interplay between tumor and nodal microenvironments for the formation of nodal premetastatic niche in head and neck cancer

• Published in: American Journal of Physiology: Cell Physiology 2023-12, Vol.325 (6), p.C1516-C1531
• Main Authors: Mastronikolis, Nicholas S, Spyropoulou, Despoina, Kyrodimos, Efthymios, Piperigkou, Zoi, Giotakis, Evangelos, Delides, Alexander, Karamanos, Nikos K
• Format: Article
• Language: English
• Subjects: Head and Neck Neoplasms - pathology; Humans; Lymph Nodes - pathology; Lymphatic Metastasis - pathology; Lymphatic Vessels; Tumor Microenvironment - physiology
• ISSN: 0363-6143; 1522-1563
• DOI: 10.1152/ajpcell.00337.2023

Head and neck cancer (HNC) encompasses a number of malignancies originating in the head and neck area. In patients with HNC, cervical lymph nodes constitute metastatic sites for cancer cells that escape primary tumors. The premetastatic niche (PMN) is a crucial concept in understanding metastatic disease. PMN refers to the microenvironment resulting mainly from primary tumor cells to foster metastatic tumor cell growth at a distant organ. Tumor microenvironment (TME) plays an important part in the pathogenesis of PMN. A significant prognostic factor is the close association between metastases of lymph nodes and organ dissemination in many different malignancies. The nodal premetastatic niche (NPMN) is a particular type of PMN located within the lymph nodes. NPMN formation is specifically important in HNC as regional lymph node metastasis commonly occurs. The formation happens when tumor cells create a supportive microenvironment within lymph nodes, facilitating their survival, growth, spread, and invasion. This complex mechanism involves multiple steps and cellular interactions between the primary tumor and tumor microenvironment. Several extracellular matrix (ECM) macromolecules, cytokines, and growth factors are implicated in this process. The aim of this article is to present the most recent data on the regulation of the lymph node PMN at molecular and cellular levels in HNC, as well as insights with respect to the relationship between primary tumor cells and the microenvironment of lymph nodes, and the formation of NPMN. We also critically discuss on potential targets for preventing or disrupting nodal metastases and identify potential biomarkers for predicting HNC outcomes.